New HIV drug could revolutionize treatment for the elderly
A new once-daily HIV drug could simplify treatment for elderly patients who have been managing the virus for decades.
Research on new medications, such as polylaminin, must follow strict international rules
The development of new medications, including polylaminin, requires adherence to strict international guidelines, particularly in clinical trials that involve control groups to assess efficacy and safety.
Yobe to establish drug abuse, rehabilitation agency
The Yobe State Government is planning to create a State Drug Abuse Prevention and Rehabilitation Agency to combat drug abuse and substance dependency in the state.
Polylaminin is promising, but must overcome clinical trials
Polylaminin shows promise as a potential treatment for severe spinal injuries but faces significant challenges in clinical testing.
Promising drug compound attacks fat from genetic roots
A new oral drug compound, TLC-2716, shows promise in significantly reducing blood fat levels linked to fatal heart diseases.
DOJ announces conviction in Minnesota meth ring linked to Sinaloa cartel
A federal court has convicted Eric Anthony Rodriguez in a meth trafficking conspiracy connected to the Sinaloa Cartel, marking a significant development in a large-scale drug trafficking investigation in Minnesota.
Are Generic Drugs Cut to Create New Drugs? … It’s a Misdiagnosis
The ongoing debate surrounding the Ministry of Health and Welfare's proposal to lower the prices of generic drugs in South Korea has raised concerns about its implications for new drug development and the pharmaceutical industry.
Capital injection: China backs AI drug makers in self-reliance drive
The Chinese government is significantly investing in AI drug manufacturers to foster self-reliance in the biotech sector, exemplified by METiS TechBio's success in funding and drug development.
The Academy of Rare Patients Greece has started: Its members will participate in the development and approval of drugs
The newly established Academy of Rare Patients in Greece aims to train its members to actively participate in the evaluation and approval processes of medical treatments at both European and international levels.
Development of an Oral Administration Nanoplatform for Continuous Tumor Destruction and Immune Induction through Joint Research of Kyung Hee University and Mokpo University
Researchers from Kyung Hee University and Mokpo University have collaboratively developed an oral lipid nanoplatform capable of inducing continuous ferroptosis and immune reprogramming in tumors, aimed at enhancing drug delivery and immune response against triple-negative breast cancer.
NDLEA moves to replace cannabis farms with lawful crops
The National Drug Law Enforcement Agency is promoting a program to replace illegal cannabis farming with legal crops to provide sustainable livelihoods in rural areas.
The CNIO closes its cancer drug development and diagnostic units
The National Center for Cancer Research (CNIO) has shut down its cancer diagnosis and drug development units while launching a new action plan focusing on artificial intelligence and computational methodologies.
The CNIO closes its cancer diagnosis and new drug development units
The National Cancer Research Center (CNIO) will close three scientific units, impacting over 20 employees amid an unprecedented crisis.
The European Union approves a drug that slows the development of type 1 diabetes
The European Commission has approved the marketing of 'Tizeld', the first drug to officially impact the progression of type 1 diabetes in the EU, as announced by the French manufacturer Sanofi.
These environmental NGOs can no longer get off the drug of state money
Former Greenpeace and Foodwatch chief Thilo Bode criticizes the German development aid system, claiming that many NGOs are dependent on government funding and lack transparency regarding their effectiveness.